Effect of coenzyme Q10 on organ damage in sepsis

被引:13
|
作者
Abitagaoglu, S. [1 ]
Akinci, S. B. [1 ]
Saricaoglu, F. [1 ]
Akinci, M. [2 ]
Zeybek, N. D. [3 ]
Muftuoglu, S. [3 ]
Aypar, U. [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Anesthesiol & Reanimat, TR-06100 Ankara, Turkey
[2] Diskapi Publ Hosp, Dept Gen Surg, Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2015年 / 116卷 / 07期
关键词
coenzyme Q10; sepsis; intestinal perforation; mitochondria; antioxidants; death rate; CECAL LIGATION; MITOCHONDRIAL DYSFUNCTION; MODEL; MORTALITY; PROTECTS;
D O I
10.4149/BLL_2015_082
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: Investigating the effects of coenzyme 010 on organ damage and survival on mice in cecal ligation perforation (CLP) model in sepsis. BACKGROUND: Coenzyme 010 is an antioxidant molecule playing an important role in mitochondria. Mitochondrial dysfunction is an important mechanism in sepsis pathophysiology. METHODS: Nintyfour Swiss Albino male mice were divided into 8 groups. CLP was performed in Group I. Coenzyme 010, 100 mg/kg subcutaneously, was given 5 hours after CLP to Group II and 20 hours after CLP to Group III. Sham operation was performed in Group IV, 100 mg/kg coenzyme Q10 subcutaneously was given 5 hours after sham operation to Group V and 20 hours after sham operation to Group VI. No operation was performed in Group VII; coenzyme 010, 100 mg/kg subcutaneously, was given to Group VIII. Antibiotics and fluid replacement were applied for 3 days. The mice still living were sacrificed at 576th hour. The organ damages were scored under light microscopy. RESULTS: The survival of Group I and Group II was lower than that of the control groups, but the survival in the Group III was similar to control groups. It was established that spleen, kidney, heart damage and total organ damage were decreased when compared to CLP group. CONCLUSIONS: Coenzyme 010 is effective in decreasing histological organ damage in sepsis (Tab. 3. Fig. 1, Ref. 30). Text in PDF www.elis.sk.
引用
收藏
页码:433 / 439
页数:7
相关论文
共 50 条
  • [21] Coenzyme Q10 and Endocrine Disorders: An Overview
    Mantle, David
    Hargreaves, Iain Parry
    ANTIOXIDANTS, 2023, 12 (02)
  • [22] Mitochondrial Dysfunctions and Role of Coenzyme Q10 in Patients with Glaucoma
    Erb, Carl
    Konieczka, Katarzyna
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2018, 235 (02) : 157 - 162
  • [23] Evaluation of the protective effect of coenzyme Q10 on hepatotoxicity caused by acute phosphine poisoning
    Shayesteh, Mohammad Reza Hooshangi
    Hami, Zahra
    Chamanara, Mohsen
    Parvizi, Mohammad Reza
    Golaghaei, Alireza
    Nassireslami, Ehsan
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2024, 38
  • [24] Coenzyme Q10 effects in neurodegenerative disease
    Spindler, Meredith
    Beal, M. Flint
    Henchcliffe, Claire
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 597 - 610
  • [25] Mitochondria and Coenzyme Q10 in the Pathogenesis of Preeclampsia
    Teran, Enrique
    Hernandez, Isabel
    Tana, Leandro
    Teran, Santiago
    Galaviz-Hernandez, Carlos
    Sosa-Macias, Martha
    Molina, Gustavo
    Calle, Andres
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [26] The Effect of Organophosphate Exposure on Neuronal Cell Coenzyme Q10 Status
    Nadia Turton
    Robert A. Heaton
    Fahima Ismail
    Sioned Roberts
    Sian Nelder
    Sue Phillips
    Iain P. Hargreaves
    Neurochemical Research, 2021, 46 : 131 - 139
  • [27] Coenzyme Q10 and the Blood-Brain Barrier: An Overview
    Mantle, David
    Hargreaves, Iain
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (08)
  • [28] Supplementation with selenium and coenzyme Q10 in critically ill patients
    Hargreaves, I. P.
    Mantle, D.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (10) : 589 - 593
  • [29] Clinical aspects of coenzyme Q10:: an update
    Littarru, GP
    Tiano, L
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (06) : 641 - 646
  • [30] Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
    Mancuso, M.
    Orsucci, D.
    Volpi, L.
    Calsolaro, V.
    Siciliano, G.
    CURRENT DRUG TARGETS, 2010, 11 (01) : 111 - 121